Citi Sticks to Its Buy Rating for Stryker (SYK)
TipRanks (Fri, 14-Aug 6:56 AM ET)
Bank of America Securities Sticks to Its Buy Rating for Stryker (SYK)
TipRanks (Tue, 11-Aug 8:55 AM ET)
Providence Medical Technology Appoints Lane Major as President & Chief Executive Officer
PRNewswire (Thu, 6-Aug 8:00 AM ET)
Stryker declares an $0.88 per share quarterly dividend
Globe Newswire (Wed, 5-Aug 9:34 AM ET)
Stryker reports second quarter 2026 operating results
Globe Newswire (Thu, 30-Jul 4:05 PM ET)
Stryker expands Mako robotics portfolio with full market release of Mako RPS
PRNewswire (Thu, 16-Jul 9:05 AM ET)
Stryker to announce second quarter 2026 financial results
Globe Newswire (Wed, 1-Jul 8:00 AM ET)
PRNewswire (Wed, 24-Jun 8:03 AM ET)
PRNewswire (Tue, 16-Jun 8:15 AM ET)
Stryker launches TPX HD power tool, supporting demanding orthopaedic procedures
PRNewswire (Tue, 2-Jun 9:03 AM ET)
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, mechanical thrombectomy systems, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
Stryker trades on the NYSE stock market under the symbol SYK.
As of August 14, 2026, SYK stock price declined to $339.78 with 892,502 million shares trading.
SYK has a beta of 0.32, meaning it tends to be less sensitive to market movements. SYK has a correlation of 0.02 to the broad based SPY ETF.
SYK has a market cap of $130.03 billion. This is considered a Large Cap stock.
Last quarter Stryker reported $7 billion in Revenue and $3.69 earnings per share. This beat revenue expectation by $14 million and exceeded earnings estimates by $.20.
In the last 3 years, SYK traded as high as $406.19 and as low as $249.98.
The top ETF exchange traded funds that SYK belongs to (by Net Assets): VTI, VOO, IVV, SPY, XLV.
SYK has underperformed the market in the last year with a price return of -9.4% while the SPY ETF gained +21.5%. However, in the short term, SYK had mixed performance relative to the market. It has outperformed in the last 3 months, returning +12.8% vs +4.8% return in SPY. But in the last 2 weeks, SYK shares have been beat by the market, returning -2.4% compared to an SPY return of +4.6%.
SYK support price is $333.43 and resistance is $348.75 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SYK shares will trade within this expected range on the day.